TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,470	3,419	3,437	1,502	1,819	1,713
Market Cap Growth	110.83%	-0.52%	128.87%	-17.43%	6.17%	62.78%
Enterprise Value	6,981	2,966	3,518	1,592	1,930	1,741
Last Close Price	126.50	57.70	57.70	29.09	35.68	33.23
PE Ratio	276.55	162.73	185.02	82.21	970.95	67.06
PS Ratio	11.08	5.13	3.54	1.87	2.59	2.32
PB Ratio	7.08	3.23	3.26	2.80	3.51	3.31
P/TBV Ratio	7.10	3.24	3.28	2.85	3.60	3.41
P/FCF Ratio	94.14	21.45	-	30.98	162.55	23.80
P/OCF Ratio	86.18	20.42	-	28.74	118.66	22.87
EV/Sales Ratio	10.35	4.45	3.63	1.98	2.75	2.36
EV/EBITDA Ratio	189.93	103.67	89.02	38.95	117.57	34.58
EV/EBIT Ratio	-	277.32	157.56	62.91	905.86	46.99
EV/FCF Ratio	87.98	18.61	-	32.84	172.54	24.19
Debt / Equity Ratio	0.04	0.04	0.11	0.29	0.31	0.25
Debt / EBITDA Ratio	1.09	1.33	2.71	3.60	8.66	2.49
Debt / FCF Ratio	0.51	0.27	-	3.25	14.39	1.79
Asset Turnover	0.54	0.53	0.89	0.95	0.88	0.96
Inventory Turnover	2.00	1.99	2.44	1.79	1.67	1.82
Quick Ratio	5.73	8.24	3.87	1.42	1.42	1.74
Current Ratio	7.03	9.91	4.95	2.29	2.67	3.69
Return on Equity (ROE)	2.57%	1.99%	2.33%	3.46%	0.36%	4.97%
Return on Assets (ROA)	0.73%	0.53%	1.28%	1.88%	0.17%	3.01%
Return on Capital (ROIC)	0.80%	0.59%	1.50%	2.30%	0.20%	3.54%
Return on Capital Employed (ROCE)	1.30%	1.00%	2.00%	4.00%	0.30%	5.60%
Earnings Yield	0.36%	0.61%	0.54%	1.22%	0.10%	1.49%
FCF Yield	1.06%	4.66%	-1.21%	3.23%	0.61%	4.20%
Dividend Yield	0.28%	0.61%	0.49%	0.11%	-	1.05%
Payout Ratio	62.31%	80.10%	8.71%	-	903.20%	73.59%
Buyback Yield / Dilution	-1.80%	-11.37%	-8.03%	-0.89%	-0.42%	0.03%
Total Shareholder Return	-1.52%	-10.76%	-7.54%	-0.77%	-0.42%	1.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.